The NHS is introducing a new treatment option, foslevodopa–foscarbidopa, for patients with advanced Parkinson’s disease. The treatment involves a portable drug infusion released around-the-clock to better manage symptoms like movement-related issues. Patients wear a small automatic pump that delivers the infusion under the skin, providing a steady release of medication to alleviate symptoms with fewer side effects. The treatment offers an alternative for patients not responding to oral medicines and can enhance quality of life by enabling more consistent symptom management.
How might the availability of this portable drug infusion change the lives of patients with advanced Parkinson’s disease, and what are the potential benefits and challenges associated with its use?
https://www.england.nhs.uk/2024/02/nhs-rolls-out-wearable-24-hour-infusion-for-advanced-parkinsons/